文献速递技术与安全CTMR

与对比剂立即过敏反应相关的危险因素:系统综述与Meta分析

Risk factors associated with immediate hypersensitivity reaction to contrast media: a systematic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2025-10-15

该系统综述与Meta分析纳入7项研究、115,043例患者和736,203次注射,评估对比剂立即过敏反应(CM-IHR)的危险因素。女性(OR 1.46)为显著危险因素,年龄增大与风险降低相关(OR 0.98);门诊状态与碘对比剂立即过敏反应风险升高相关(OR 3.08);既往碘对比剂过敏反应史未达统计学显著。

要点

  • 女性是对比剂立即过敏反应的显著危险因素(OR 1.46,95%CI 1.33-1.59)。
  • 年龄增大与对比剂立即过敏反应风险降低相关(OR 0.98,95%CI 0.98-0.99)。
  • 门诊状态与碘对比剂立即过敏反应风险升高显著相关(OR 3.08,95%CI 1.13-8.44)。

核心结论

  • 女性是对比剂立即过敏反应的显著危险因素,年龄增大与风险降低相关,门诊状态与碘对比剂立即过敏反应显著相关,既往碘对比剂过敏反应史未确定为显著危险因素;因可用研究数量少且异质性大,这些发现需谨慎解读。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Ovid、Web of Science和Cochrane Library截至2024年12月,最终纳入7项研究,共115,043例患者和736,203次注射,采用纽卡斯尔-渥太华量表评估偏倚风险,合并各危险因素的OR及95%CI,用Higgins I2检验评估异质性。

诊断标准与关键数值

  • 女性对比剂立即过敏反应的合并OR为1.46(95%CI 1.33-1.59)。
  • 年龄对比剂立即过敏反应的合并OR为0.98(95%CI 0.98-0.99)。
  • 哮喘史对比剂立即过敏反应的合并OR为1.12(95%CI 0.95-1.33;I2=0%),未提示为显著危险因素。
  • 门诊状态对碘对比剂立即过敏反应的合并OR为3.08(95%CI 1.13-8.44)。
  • 既往碘对比剂过敏反应史对碘对比剂立即过敏反应的合并OR为7.49(95%CI 0.42-135.09,I2=87%),未达统计学显著且异质性高。

临床应用与阅片要点

  • 原文结论指出女性是对比剂立即过敏反应的显著危险因素,年龄增大与风险降低相关。
  • 原文结论指出门诊状态与碘对比剂立即过敏反应显著相关。
  • 原文结论指出既往碘对比剂过敏反应史未确定为显著危险因素。
  • 原文结论指出因可用研究数量少且异质性大,这些发现需谨慎解读。

局限性

  • 可用研究数量少。
  • 异质性大(既往碘对比剂过敏反应史分析I2=87%)。
  • 原文结论指出这些发现需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the risk factors associated with immediate hypersensitivity reactions to contrast media (CM-IHR).

MATERIALS AND METHODS: A systematic search was conducted in PubMed, Embase, Ovid, Web of Science database and the Cochrane Library up to December 2024 to identify studies in which risk factors associated with CM-IHR were explored. The Newcastle-Ottawa Scale was used to assess the risk of bias. Odds ratios (ORs) with 95% confidence intervals (CIs) for each risk factor were pooled from the selected studies. Heterogeneity was evaluated via the Higgins I2 test.

RESULTS: From 8,342 citations, seven were ultimately included in the meta-analysis, encompassing a total of 115,043 patients and 736,203 injections. The methodological quality was rated as high in six studies and moderate in one. Four studies investigated iodinated CM (ICM), while 3 investigated gadolinium-based contrast agent. Female sex (OR 1.46; 95 % CI 1.33-1.59) was identified as a significant risk factor for CM-IHR, and age showed an inverse association with risk (OR 0.98; 95 % CI 0.98-0.99). Asthma history was not suggested as a significant risk factor (OR 1.12; 95 % CI, 0.95-1.33; I2 = 0 %). For ICM-IHR specifically, outpatient status was associated with higher risk (OR, 3.08; 95 % CI, 1.13-8.44). Notably, pooled analysis of two studies suggested a trend toward increased risk with prior history of hypersensitivity reaction to ICM; however, this association was not statistically significant and was accompanied by high heterogeneity (OR 7.49; 95 % CI, 0.42-135.09, I2 = 87 %).

CONCLUSIONS: Our systematic review and meta-analysis suggest that female sex was a significant risk factor for CM-IHR, whereas increasing age was associated with a lower risk. Outpatient status showed a significant association with ICM-IHR. Prior history of hypersensitivity reaction to ICM was not identified as a significant risk factor. Given the small number of available studies and substantial heterogeneity, these findings should be interpreted with caution.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Huang W, He C, Chen Y, et al. Risk factors associated with immediate hypersensitivity reaction to contrast media: a systematic review and meta-analysis. Eur J Radiol. 2025. PMID: 41175815. doi:10.1016/j.ejrad.2025.112472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。